We propose that discussions of benzodiazepines in the current psychiatric literature have become negatively biased and have strayed from the scientific evidence base. We advocate returning to the evidence in discussing benzodiazepines and adhering to clear definitions and conceptual rigour in commentary about them.

Benzodiazepines: It's time to return to the evidence / Silberman E.; Balon R.; Starcevic V.; Shader R.; Cosci F.; Fava G.A.; Nardi A.E.; Salzman C.; Sonino N.. - In: BRITISH JOURNAL OF PSYCHIATRY. - ISSN 0007-1250. - ELETTRONICO. - 218:(2021), pp. 125-127. [10.1192/bjp.2020.164]

Benzodiazepines: It's time to return to the evidence

Cosci F.;
2021

Abstract

We propose that discussions of benzodiazepines in the current psychiatric literature have become negatively biased and have strayed from the scientific evidence base. We advocate returning to the evidence in discussing benzodiazepines and adhering to clear definitions and conceptual rigour in commentary about them.
2021
218
125
127
Silberman E.; Balon R.; Starcevic V.; Shader R.; Cosci F.; Fava G.A.; Nardi A.E.; Salzman C.; Sonino N.
File in questo prodotto:
File Dimensione Formato  
Silberman et al. benzodiazepines-its-time-to-return-to-the-evidence_BJP 2021.pdf

Accesso chiuso

Descrizione: paper
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 321.23 kB
Formato Adobe PDF
321.23 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1239612
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 40
social impact